Cargando…

Inhibition of ERK 1/2 kinases prevents tendon matrix breakdown

Tendon extracellular matrix (ECM) mechanical unloading results in tissue degradation and breakdown, with niche-dependent cellular stress directing proteolytic degradation of tendon. Here, we show that the extracellular-signal regulated kinase (ERK) pathway is central in tendon degradation of load-de...

Descripción completa

Detalles Bibliográficos
Autores principales: Blache, Ulrich, Wunderli, Stefania L., Hussien, Amro A., Stauber, Tino, Flückiger, Gabriel, Bollhalder, Maja, Niederöst, Barbara, Fucentese, Sandro F., Snedeker, Jess G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994809/
https://www.ncbi.nlm.nih.gov/pubmed/33767224
http://dx.doi.org/10.1038/s41598-021-85331-1
_version_ 1783669833039085568
author Blache, Ulrich
Wunderli, Stefania L.
Hussien, Amro A.
Stauber, Tino
Flückiger, Gabriel
Bollhalder, Maja
Niederöst, Barbara
Fucentese, Sandro F.
Snedeker, Jess G.
author_facet Blache, Ulrich
Wunderli, Stefania L.
Hussien, Amro A.
Stauber, Tino
Flückiger, Gabriel
Bollhalder, Maja
Niederöst, Barbara
Fucentese, Sandro F.
Snedeker, Jess G.
author_sort Blache, Ulrich
collection PubMed
description Tendon extracellular matrix (ECM) mechanical unloading results in tissue degradation and breakdown, with niche-dependent cellular stress directing proteolytic degradation of tendon. Here, we show that the extracellular-signal regulated kinase (ERK) pathway is central in tendon degradation of load-deprived tissue explants. We show that ERK 1/2 are highly phosphorylated in mechanically unloaded tendon fascicles in a vascular niche-dependent manner. Pharmacological inhibition of ERK 1/2 abolishes the induction of ECM catabolic gene expression (MMPs) and fully prevents loss of mechanical properties. Moreover, ERK 1/2 inhibition in unloaded tendon fascicles suppresses features of pathological tissue remodeling such as collagen type 3 matrix switch and the induction of the pro-fibrotic cytokine interleukin 11. This work demonstrates ERK signaling as a central checkpoint to trigger tendon matrix degradation and remodeling using load-deprived tissue explants.
format Online
Article
Text
id pubmed-7994809
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-79948092021-03-29 Inhibition of ERK 1/2 kinases prevents tendon matrix breakdown Blache, Ulrich Wunderli, Stefania L. Hussien, Amro A. Stauber, Tino Flückiger, Gabriel Bollhalder, Maja Niederöst, Barbara Fucentese, Sandro F. Snedeker, Jess G. Sci Rep Article Tendon extracellular matrix (ECM) mechanical unloading results in tissue degradation and breakdown, with niche-dependent cellular stress directing proteolytic degradation of tendon. Here, we show that the extracellular-signal regulated kinase (ERK) pathway is central in tendon degradation of load-deprived tissue explants. We show that ERK 1/2 are highly phosphorylated in mechanically unloaded tendon fascicles in a vascular niche-dependent manner. Pharmacological inhibition of ERK 1/2 abolishes the induction of ECM catabolic gene expression (MMPs) and fully prevents loss of mechanical properties. Moreover, ERK 1/2 inhibition in unloaded tendon fascicles suppresses features of pathological tissue remodeling such as collagen type 3 matrix switch and the induction of the pro-fibrotic cytokine interleukin 11. This work demonstrates ERK signaling as a central checkpoint to trigger tendon matrix degradation and remodeling using load-deprived tissue explants. Nature Publishing Group UK 2021-03-25 /pmc/articles/PMC7994809/ /pubmed/33767224 http://dx.doi.org/10.1038/s41598-021-85331-1 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Blache, Ulrich
Wunderli, Stefania L.
Hussien, Amro A.
Stauber, Tino
Flückiger, Gabriel
Bollhalder, Maja
Niederöst, Barbara
Fucentese, Sandro F.
Snedeker, Jess G.
Inhibition of ERK 1/2 kinases prevents tendon matrix breakdown
title Inhibition of ERK 1/2 kinases prevents tendon matrix breakdown
title_full Inhibition of ERK 1/2 kinases prevents tendon matrix breakdown
title_fullStr Inhibition of ERK 1/2 kinases prevents tendon matrix breakdown
title_full_unstemmed Inhibition of ERK 1/2 kinases prevents tendon matrix breakdown
title_short Inhibition of ERK 1/2 kinases prevents tendon matrix breakdown
title_sort inhibition of erk 1/2 kinases prevents tendon matrix breakdown
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994809/
https://www.ncbi.nlm.nih.gov/pubmed/33767224
http://dx.doi.org/10.1038/s41598-021-85331-1
work_keys_str_mv AT blacheulrich inhibitionoferk12kinasespreventstendonmatrixbreakdown
AT wunderlistefanial inhibitionoferk12kinasespreventstendonmatrixbreakdown
AT hussienamroa inhibitionoferk12kinasespreventstendonmatrixbreakdown
AT staubertino inhibitionoferk12kinasespreventstendonmatrixbreakdown
AT fluckigergabriel inhibitionoferk12kinasespreventstendonmatrixbreakdown
AT bollhaldermaja inhibitionoferk12kinasespreventstendonmatrixbreakdown
AT niederostbarbara inhibitionoferk12kinasespreventstendonmatrixbreakdown
AT fucentesesandrof inhibitionoferk12kinasespreventstendonmatrixbreakdown
AT snedekerjessg inhibitionoferk12kinasespreventstendonmatrixbreakdown